Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
3.01
|
3.17
|
3.08
|
3.02
|
3.24
|
3.07
|
|
|
4 113 606.35
|
10 090.00
|
2.92
|
3.00
|
3.07
|
2.92
|
3.09
|
2.97
|
|
|
4 157 957.01
|
7 810.00
|
2.92
|
3.07
|
2.78
|
2.74
|
3.029
|
2.92
|
|
|
7 438 719.29
|
16 411.00
|
2.75
|
2.79
|
2.80
|
2.70
|
2.91
|
2.76
|
|
|
6 026 852.17
|
13 563.00
|
2.83
|
2.85
|
2.94
|
2.785
|
3.10
|
2.84
|
|
|
8 824 115.16
|
13 978.00
|
2.80
|
2.92
|
2.87
|
2.75
|
2.93
|
2.89
|
|
|
6 995 174.45
|
15 885.00
|
2.85
|
2.88
|
2.99
|
2.84
|
2.99
|
2.855
|
|
|
8 010 724.82
|
12 872.00
|
3.03
|
3.25
|
3.37
|
3.03
|
3.42
|
3.04
|
|
|
6 538 696.95
|
12 442.00
|
3.37
|
3.41
|
3.41
|
3.36
|
3.53
|
3.37
|
|
|
5 526 544.48
|
10 741.00
|
3.38
|
3.46
|
3.49
|
3.38
|
3.63
|
3.40
|
|
|
6 235 039.19
|
11 589.00
|
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the research, development, and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company was founded in 2017 and is headquartered in South San Francisco, California.